Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ethanolamine kinase 1 pseudogene (ETNK1 pseudogene)
- Target
- ETNK1 pseudogene
- Molecular classification
- Pseudogene, Other
01
Overview
Ethanolamine kinase 1 pseudogene (ENSG00000250345; LOC100419356) is a genomic DNA segment which resembles the functional gene "ethanolamine kinase 1" (ETNK1) but has lost its protein-coding ability due to disabling mutations, truncations, or lack of regulatory elements. Pseudogenes are frequently transcribed at low levels, but most are nonfunctional and considered "junk DNA". Although some pseudogenes can produce non-coding RNAs affecting gene regulation, there is no evidence that this particular pseudogene is functional in a regulatory context. Pseudogenes can complicate molecular genetic studies by being mistaken for functional genes or interfering with gene amplification and characterization. In summary, ENSG00000250345 (LOC100419356) is a pseudogene, not a receptor or therapeutic target, and does not participate in canonical molecular classifications, biological functions, disease roles, nor is it involved in drug interactions or biomarker applications
- Other names
- Ethanolamine kinase 1 pseudogeneETNK1 pseudogeneLOC100419356
02
Mechanism of action
None. There is no mechanism of action, as no therapies are directed at this pseudogene
03
Biological functions
No direct biological function as it is a nonfunctional, gene-like DNA segmentSome pseudogenes may be transcribed to non-coding RNAs which could potentially regulate gene expression (as competitive endogenous RNAs or through chromatin modification), but this is highly variable and not established for this specific pseudogene
04
Disease associations
Other: Few pseudogenes have been implicated via regulatory RNAs in diseases such as cancer, but their roles are generally indirect, poorly characterized, and there is no evidence for disease association for "ethanolamine kinase 1 pseudogene"
05
Safety considerations
None. This pseudogene poses no therapeutic safety concerns, as it is not targeted in therapy
06
Interacting drugs
None.
07
Biomarkers
None.
Beyond the preview
Go deeper on Ethanolamine kinase 1 pseudogene (ETNK1 pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ethanolamine kinase 1 pseudogene (ETNK1 pseudogene).